Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial

Teulings, H.E.; Tjin, E.P.M.; Willemsen, K.J.; Kleij, S. van der; Meulen, S. ter; Kemp, E.H.; ... ; Luiten, R.M. (2018)

Article / Letter to editor

• Melanoma
• immunotherapy
• vitiligo
• cutaneous metastases

• All authors: Teulings, H.E.; Tjin, E.P.M.; Willemsen, K.J.; Kleij, S. van der; Meulen, S. ter; Kemp, E.H.; Krebbers, G.; Noesel, C.J.M. van; Franken, C.L.M.C.; Drijfhout, J.W.; Melief, C.J.M.; Nieuweboer-Krobotova, L.; Nieweg, O.E.; Hage, J.A. van der; Veen, J.P.W. van der; Relyveld, G.N.; Luiten, R.M.
• Date: 2018-12-31
• Journal: OncoImmunology
• Volume: 7
• Issue: 4
• DOI: doi:10.1080/2162402X.2017.1419113
• Link: https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1419113